Results

Total Results: 1,246 records

Showing results for "hepatitis c".
Users also searched for: hepatitis c

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/telehealth-acute-chronic_research-protocol.pdf
    February 15, 2017 - diagnosis and treatment of infectious disease or specific conditions (e.g., upper respiratory infection, hepatitisC, skin infections) or decisions (e.g., stewardship of antibiotics or antimicrobials, selection of … Characteristics of the providers and patients involved c.
  2. hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2017.jsp
    January 01, 2017 - STATE-SPECIFIC RESTRICTIONS Table C.1. … Table C.1. … Mycoses 10,755 27.56 28.10 2.0 5: HIV infection 7,495 26.99 27.66 2.5 6: Hepatitis … including parasitic 4,117 13.46 14.09 4.7 9: Sexually transmitted infections (not HIV or hepatitis … Andrews R, Kassed C, Nagamine M.
  3. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
    January 01, 2011 - disorders 7,450 0.09% 540: Cesarean delivery 264,965 3.30% 541: Vaginal delivery w sterilization &/or D&C … 17,490 0.22% 542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 1,699 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 4,462 0.06% 545: Ectopic pregnancy … abortion diagnoses w/o procedure 11,651 0.15% 563: Threatened abortion 12,713 0.16% 564: Abortion w/o D&C,
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
    November 01, 2012 - Citations excluded at the full-text level are listed in Appendix C in the full report, along with the … Gisondi P, Del Giglio M, Cotena C, et al. … Gisondi P, Cotena C, Tessari G, et al. … Magliocco MA, Lozano AM, Van Saders C, et al.
  5. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
    January 01, 2012 - Percent of Total 540: Cesarean delivery 521,823 3.88% 541: Vaginal delivery w sterilization &/or D&C … 26,033 0.19% 542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 3,015 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 7,331 0.05% 545: Ectopic pregnancy … abortion diagnoses w/o procedure 22,592 0.17% 563: Preterm labor 23,187 0.17% 564: Abortion w/o D&C,
  6. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
    January 01, 2011 - Percent of Total 540: Cesarean delivery 534,930 3.84% 541: Vaginal delivery w sterilization &/or D&C … 28,625 0.21% 542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 3,223 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 9,667 0.07% 545: Ectopic pregnancy … abortion diagnoses w/o procedure 22,748 0.16% 563: Threatened abortion 25,561 0.18% 564: Abortion w/o D&C,
  7. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
    January 01, 2010 - Percent of Total 540: Cesarean delivery 539,914 3.88% 541: Vaginal delivery w sterilization &/or D&C … 29,710 0.21% 542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 3,468 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 8,021 0.06% 545: Ectopic pregnancy … abortion diagnoses w/o procedure 23,183 0.17% 563: Threatened abortion 26,513 0.19% 564: Abortion w/o D&C,
  8. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
    January 01, 2013 - disorders 12,625 0.09% 540: Cesarean delivery 553,991 3.87% 541: Vaginal delivery w sterilization &/or D&C … 27,470 0.19% 542: Vaginal delivery w complicating procedures exc sterilization &/or D&C 3,091 0.02% … 544: D&C, aspiration curettage or hysterotomy for obstetric diagnoses 7,164 0.05% 545: Ectopic pregnancy … abortion diagnoses w/o procedure 23,907 0.17% 563: Preterm labor 22,029 0.15% 564: Abortion w/o D&C,
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
    October 01, 2012 - ...................................................................................... 26 Appendix C. … Appendix C shows the questionnaire matrix that was sent to the experts. 2.4 Check for qualitative … Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in … Goraya N, Simoni J, Jo C, et al. … Evidence Table Appendix C. Questionnaire Matrix
  10. psnet.ahrq.gov/sites/default/files/2023-11/spotlight_case_the_risk_of_malpositioned.pdf
    January 01, 2023 - on the patient’s body habitus, making sure that the bolster is neither too tight nor too loose; (C) … Gawande RS, Bailey CR, Jones C, et al. … Patel BB, Andrade C, Doraiswamy V, et al. … Gubler C, Wildi SM, Bauerfeind P. Liver injury during PEG tube placement: report of two cases. … Korula J, Harma C. A simple and inexpensive method of removal or replacement of gastrostomy tubes.
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
    January 01, 2015 - c. … Charoenkwan K, Kietpeerakool C. … Hepatitis A immunisation in persons not previously exposed to hepatitis A. … Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C. … Main C, Knight B, Moxham T, et al.
  12. www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-pregnancy-screening-2009
    May 15, 2009 - screening for other sexually transmitted diseases in pregnancy, including gonorrhea, chlamydial infection, hepatitis … [PMID: 15306757] Wolff T, Shelton E, Sessions C, Miller T.
  13. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions
    October 20, 2016 - for adolescents) Alcohol Use Disorders Identification Test (AUDIT), its abbreviated version (AUDIT-C) … health symptoms/disorders; alcohol-related liver problems, including fatty liver disease, alcoholic hepatitis
  14. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan18/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
    May 15, 2013 - including, but not limited to: mental health disorders, sexually transmitted infection/HIV transmission, hepatitis … B or C transmission, unintended pregnancies/pregnancy complications, respiratory infections, cardiovascular
  15. integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/implement-mat-for-oud/screening-and-diagnosis
    January 01, 2018 - of opioid use disorder; Other relevant medical conditions (i.e., pregnancy testing, liver function, hepatitis … B and C testing, HIV testing); and Other relevant psychiatric disorders, including depression and specifically
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - ...................................................................................... 19 Appendix C. … Gaujoux-Viala C, Giampietro C, Gaujoux T, et al. Scleritis: a paradoxical effect of etanercept? … Sandborg C, Mellins ED. A new era in the treatment of systemic juvenile idiopathic arthritis. … C-reactive protein and ferritin normalized within this interval in >80%. … AE’s included bacterial infection in 2 patients and hepatitis in 1 Key Question 2: In children with
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - ...................................................................................... 19 Appendix C. … Gaujoux-Viala C, Giampietro C, Gaujoux T, et al. Scleritis: a paradoxical effect of etanercept? … Sandborg C, Mellins ED. A new era in the treatment of systemic juvenile idiopathic arthritis. … C-reactive protein and ferritin normalized within this interval in >80%. … AE’s included bacterial infection in 2 patients and hepatitis in 1 Key Question 2: In children with
  18. www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-abuse-screening-1996
    January 01, 1996 - complications from injecting contaminated materials (e.g., human immunodeficiency virus [HIV] infection, hepatitis … Colmorgen GHC, Johnson C, Zazzarino MA, et al. … Chasnoff IJ, Griffith DR, Freier C, Murray J. … Wickizer T, Maynard C, Atherly A, et al. … Power R, Hartnoll R, Chalmers C.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
    January 15, 2016 - Research Review Citation: Chinnadurai S, Snyder K, Sathe N, Fonnesbeck C, Morad A, Likis FE, Surawicz … T, Ness G, Ficzere C, McPheeters ML. … Peer reviewer #1 Methods Fig C- Final Health Outcomes: is there a causation for problems with thyroid … Timolol – 64% clearance c. intralesionalTriamcinolone – 54% d.
  20. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
    October 01, 2017 - Patient is likely to have adverse reactions to statins. c. … abnormal blood cholesterol, represented HDL-C < 40 mg/dL or LDL-C > 130 mg/dL Grade B and C "Diabetes … " Type 1 and Type 2 Diabetes Grade B and C "Hypertension" high blood pressure Grade B and C " … the work group, not all liver conditions clearly exclude a recommendation for statin therapy (e.g., Hepatitis … B and C).

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive